▲ Peaking
Health
Pelacarsen, a promising drug for an inherited heart risk, flops, stunning doctors
A high‑profile heart drug collapsed in its pivotal trial, shattering expectations across the medical community.
Clinical Trial
24 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Clinical Trial
This hub groups 24 separate news trends connected to Clinical Trial, spanning August 5, 2026 through November 7, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 173 article observations and 167 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
Servier’s $1.5B bet on Edgewise drug fails five months in
Servier’s $1.6 billion Edgewise trial fails, ending its biggest bet on Becker muscular dystrophy.
◼ Archived
Health
🔮 fades ✓
B-Vitamin Supplement Can Treat Psoriasis, a Skin Condition with No Cure
Pantethine, a B‑vitamin derivative, shows early promise in easing psoriasis, sparking media attention from health journals to tabloids.
◼ Archived
Health
🔮 fades ✓
Single dose of fast-acting psychedelic nasal spray shows promise for stubborn depression
A single dose of a toad‑venom nasal spray cuts depression symptoms in early trials, sparking global health interest.
◼ Archived
Health
🔮 fades ✓
Simple exercise done just once a week could help lower blood pressure
A two‑minute weekly wall hold is sparking global health headlines as a potential shortcut to lower high blood pressure.
◼ Archived
Health
🔮 fades ✓
Nose Spray Made From Toad Venom Compound Quickly Eases Depression For Weeks in Clinical Trial
A single dose of psychedelic nasal spray has shown promise in easing stubborn depression for weeks.
◼ Archived
Health
🔮 fades ✓
Millions of people high blood pressure pills daily, now scientists are testing a small device that stimul
Millions rely on pills for hypertension while a tiny ear‑clip device sparks debate over a drug‑free alternative
◼ Archived
Health
🔮 fades ✓
A precision T-cell therapy stalls treatment-resistant cancers in clinical trial
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Probiotics May Protect From Signs of Early Cognitive Decline, Clinical Trial Finds
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
AbbVie’s next-gen Crohn’s disease combo beats Skyrizi in phase 2 trial
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
High-fiber diet vs metformin: Which is better for blood sugar control, weight loss?
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Inside the study for a remedy to fight Congo’s deadliest Ebola outbreak
DR Congo’s massive Obeldesivir trial aims to halt the deadliest Ebola outbreak yet
◼ Archived
Business
🔮 fades ✓
Novartis’ TREM2 drug fails Phase 2 ALS trial
Novartis' ALS drug fails in mid-stage trial, halting development
◼ Archived
Health
🔮 fades ✓
Laughter could be best medicine for lung disease patients
A simple laugh may ease the breathlessness of COPD, turning humor into a surprising medical aid.
◼ Archived
Business
🔮 fades ✓
Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial
A childhood‑obesity drug once reserved for adults now shows weight‑loss promise in kids as young as six.
◼ Archived
Health
🔮 fades ✓
Arthritis Drug Restores Up to 100% of Hair in Patients With Severe Alopecia
Arthritis drug unexpectedly reverses severe baldness in patients with alopecia.
◼ Archived
Health
🔮 fades ✓
Does AF Ablation Work? That’s in Question After PVI-SHAM-AF
New sham‑controlled trial shows AFib ablation cuts irregular beats but fails to lift patients’ quality of life.
◼ Archived
Business
BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
BioNTech and Roche have halted a mid-stage cancer vaccine trial after more deaths occurred in the treatment group than in the control group.
◼ Archived
Health
🔮 fades ✓
Cell therapy substantially reduces severe rheumatoid arthritis in first clinical trial
A cancer therapy has shown promise in treating severe rheumatoid arthritis, offering new hope to patients.
◼ Archived
Health
🔮 fades ✓
Scientists Put Three Weight-Loss Diets Head to Head. Only One Changed The Liver.
A clinical trial has found that the keto diet may have unique benefits for liver health compared to other popular weight-loss diets.
◼ Archived
Business
🔮 fades ✓
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Shares of Moderna have doubled after its cancer vaccine trial with Merck met key endpoints.
◼ Archived
Business
Moderna surges as Merck-partnered melanoma vaccine cuts recurrence in large trial
Moderna's stock surges as a melanoma vaccine developed with Merck shows promise in a large trial
◼ Archived
Health
🔮 fades ✓
First poo transplant to treat food allergy in people has ‘exciting’ results
A small trial of fecal transplants shows promise in treating food allergies, but the method is not yet widely accepted.
◼ Archived
Health
🔮 fades ✓
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Moderna's Phase 1 Ebola vaccine trial begins as the outbreak in DR Congo continues to spread